Innovotech (CVE:IOT) Hits New 1-Year Low – Should You Sell?

Innovotech Inc. (CVE:IOTGet Free Report) reached a new 52-week low during mid-day trading on Wednesday . The stock traded as low as C$0.07 and last traded at C$0.08, with a volume of 31000 shares changing hands. The stock had previously closed at C$0.08.

Innovotech Stock Performance

The firm has a market capitalization of C$4.36 million, a P/E ratio of -11.75 and a beta of 2.64. The company has a debt-to-equity ratio of 12.55, a quick ratio of 5.81 and a current ratio of 2.63. The firm has a 50 day moving average price of C$0.11 and a two-hundred day moving average price of C$0.19.

About Innovotech

(Get Free Report)

Innovotech Inc provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; MBEC Assay kit, a petri dish for biofilms, which are used for research and medical device testing of microbial biofilms; and AgreGuard, an antimicrobial for crop protection. It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; antimicrobial and anti-biofilm materials; BEST assay testing; implanted medical devices; bacteriophage testing; and analytical services.

Read More

Receive News & Ratings for Innovotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovotech and related companies with MarketBeat.com's FREE daily email newsletter.